A Novel Drug Candidate For Alzheimer's Disease Treatment: Gx-50 ...

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

Atypon Full text links

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel PermalinkPermalinkCopyDisplay options Display options Format AbstractPubMedPMID

Page navigation

• Title & authors
• Abstract
• Publication types
• MeSH terms
• Substances
• LinkOut - more resources

Title & authors Abstract Publication types MeSH terms Substances LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

This study focused on a promising drug candidate, N-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenyl-acrylamide (gx-50), a compound extracted from Sichuan pepper (Zanthoxylum Bungeanum), to determine whether it would be an effective therapeutic for Alzheimer's disease (AD) via biological experiments. In vivo, we determined the pharmacokinetic profile of gx-50 and evaluated the effect of gx-50 on the cognitive abilities of amyloid-β protein precursor transgenic (AβPP-Tg) mice by Morris water maze testing. In addition, we examined the effects of gx-50 on amyloid-β (Aβ) oligomers in the brains of AβPP-Tg mice by immunohistochemistry. In vitro, we observed a direct effect of gx-50 on Aβ oligomers by atomic force microscopy, detected the neuroprotective effects of gx-50 by western blotting and cell apoptosis assays, and measured its effects on intracellular calcium currents by laser confocal microscopy. Experiments in vivo showed that gx-50 could penetrate the blood brain barrier and improve the cognitive abilities of mice. Moreover, gx-50 treatment decreased the accumulation of Aβ oligomers in the cerebral cortex. The results in vitro demonstrated that gx-50 could disassemble Aβ oligomers, inhibit Aβ-induced neuronal apoptosis and apoptotic gene expression, and reduce neuronal calcium toxicity. These results strongly suggest that gx-50 is a potential candidate drug for treating AD.

PubMed Disclaimer

Publication types

• Research Support, Non-U.S. Gov't Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Acrylamides / pharmacology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Acrylamides / therapeutic use Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Alzheimer Disease / complications Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Alzheimer Disease / drug therapy* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Alzheimer Disease / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Alzheimer Disease / pathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Amyloid beta-Peptides / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Amyloid beta-Peptides / toxicity Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Amyloid beta-Protein Precursor / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Animals Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Apoptosis / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Brain / cytology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Brain / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Brain / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Calcium / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cells, Cultured Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cognition Disorders / etiology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cognition Disorders / prevention & control Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Disease Models, Animal Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Maze Learning / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mice Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mice, Transgenic Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mutation / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neurons / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neuroprotective Agents / chemistry Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neuroprotective Agents / pharmacokinetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neuroprotective Agents / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Peptide Fragments / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Peptide Fragments / toxicity Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Phytotherapy / methods* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Plant Preparations / pharmacokinetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Plant Preparations / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Plaque, Amyloid / drug therapy Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Presenilin-1 / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Rats Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Rats, Sprague-Dawley Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Time Factors Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Zanthoxylum / chemistry* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• bcl-2-Associated X Protein / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Acrylamides Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Amyloid beta-Peptides Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Amyloid beta-Protein Precursor Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neuroprotective Agents Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• PSEN1 protein, human Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Peptide Fragments Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Plant Preparations Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Presenilin-1 Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• amyloid beta-protein (1-42) Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• bcl-2-Associated X Protein Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• lemairamin Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Calcium Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal

Full text links [x] Atypon [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.